RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
151 hedge funds and large institutions have $1.49B invested in Revance Therapeutics, Inc. in 2020 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 51 increasing their positions, 45 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
1% less funds holding
Funds holding: 153 → 151 (-2)
51% less call options, than puts
Call options by funds: $6.53M | Put options by funds: $13.2M
Holders
151
Holding in Top 10
2
Calls
$6.53M
Puts
$13.2M
Top Buyers
| 1 | +$80.8M | |
| 2 | +$19.2M | |
| 3 | +$13.1M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$9.42M |
| 5 |
JPMorgan Chase & Co
New York
|
+$7M |
Top Sellers
| 1 | -$23.3M | |
| 2 | -$10.1M | |
| 3 | -$8.35M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$4.07M |